AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Addex Therapeutics Ltd (ADXN)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

7.39

-0.41 (-5.26%)

At close: Jan 14, 2025, 9:00 PM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07	FY06
Revenue	1.61M	1.42M	2.92M	3.61M	2.76M	6.04M	499.89K	17.33K	40.30K	85.40K	91.76K	121.09K	2.82M	1.98M	4.09M	26.81M	486.93K	4.74M
Cost of Revenue	6.94M	14.62M	12.82M	10.37M	230.10K	144.17K	29.76K	17.33K	40.30K	85.40K	91.76K	1.27M	27.99M	31.16M	n/a	n/a	-156.03K	n/a
Gross Profit	-5.32M	-13.20M	-9.90M	-6.76M	2.53M	5.90M	470.13K	n/a	n/a	n/a	n/a	-1.15M	-25.16M	-29.19M	4.09M	26.81M	642.96K	4.74M
Operating Income	-10.28M	-20.52M	-15.51M	-12.24M	-14.83M	-1.42M	-3.24M	-3.13M	-3.87M	-1.80M	-14.46M	-27.01M	-30.97M	-33.60M	-43.05M	-24.87M	-37.62M	-20.90M
Interest Income	63.96K	29.25K	5.32K	35.30K	36.87K	85.87K	n/a	27.00	39.86K	1.59K	4.13K	22.66K	72.20K	97.25K	362.13K	3.31M	2.55M	241.99K
Pretax Income	-10.56M	-20.80M	-15.35M	-12.86M	-14.78M	-1.64M	-3.28M	-3.15M	-4.20M	-1.77M	-14.46M	-26.61M	-31.14M	-33.65M	42.69M	-22.07M	-35.09M	-20.54M
Net Income	-10.56M	-20.80M	-15.35M	-12.86M	-14.78M	-1.64M	-3.28M	-3.15M	-4.20M	-1.77M	-14.46M	-26.61M	-31.14M	-33.65M	-42.69M	-22.07M	-35.09M	-20.54M
Selling & General & Admin	7.20M	7.30M	5.14M	5.15M	4.26M	4.72M	2.20M	1.52M	1.57M	1.55M	6.47M	12.85M	6.73M	6.43M	7.60M	7.55M	10.77M	n/a
Research & Development	2.75M	14.67M	12.84M	10.37M	12.45M	2.37M	841.31K	819.33K	761.22K	258.06K	2.22M	4.76M	4.76M	31.16M	39.96M	44.19M	12.21M	9.77M
Other Expenses	1.94M	-22.52K	444.00K	336.68K	648.16K	382.99K	197.67K	799.70K	311.82K	-9.44K	5.77M	9.40M	-919.55K	-2.02M	n/a	-67.33K	25.90M	15.98M
Operating Expenses	11.89M	21.94M	18.42M	15.86M	17.37M	7.47M	3.24M	3.14M	2.64M	1.80M	14.46M	27.01M	5.81M	35.57M	47.56M	51.68M	38.11M	25.76M
Interest Expense	21.61K	48.90K	63.01K	69.50K	128.52K	220.17K	45.35K	6.92K	152.21K	n/a	n/a	n/a	239.37K	144.81K	n/a	501.88K	8.54K	30.45K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	11.89M	21.94M	18.42M	15.86M	17.37M	7.47M	3.24M	3.14M	2.64M	1.80M	14.46M	27.01M	33.80M	35.57M	47.56M	51.68M	38.11M	25.76M
Income Tax	n/a	123.91K	116.38K	207.76K	429.01K	1.00	n/a	6.92K	152.21K	-21.68K	3.23K	-398.93K	72.20K	97.25K	171.13M	3.31M	2.54M	346.91K
Shares Outstanding (Basic)	74.31M	45.18M	34.12M	26.68M	26.43M	23.29M	12.94M	11.41M	10.85M	9.98M	9.07M	7.91M	1.24M	986.06K	955.78K	956.03K	836.15K	476.53K
Shares Outstanding (Diluted)	74.31M	45.18M	34.12M	26.68M	26.43M	23.29M	12.94M	11.41M	10.85M	9.98M	9.07M	7.91M	1.24M	986.06K	955.78K	956.03K	836.15K	476.53K
EPS (Basic)	-0.14	-0.46	-0.45	-0.48	-0.56	-0.07	-0.25	-0.28	-0.39	-0.18	-1.6	-3.36	-25.14	-34.12	-44.67	-23.08	-41.96	-43.11
EPS (Diluted)	-0.14	-0.46	-0.45	-0.48	-0.56	-0.07	-0.25	-0.28	-0.39	-0.18	-1.6	-3.36	-25.14	-34.12	-44.67	-23.08	-41.96	-43.11
EBITDA	-10.23M	-20.23M	-14.94M	-12.41M	-14.32M	-1.51M	-3.22M	-3.12M	-2.61M	-1.71M	-13.79M	-24.87M	-28.05M	-30.56M	-39.86M	-19.55M	-33.26M	-17.99M
Depreciation & Amortization	305.95K	323.14K	347.61K	378.75K	333.84K	2.94K	15.25K	25.76K	25.88K	110.14K	662.55K	2.10M	2.93M	2.94M	2.84M	2.02M	1.80M	2.52M